Cell And Gene Therapy Videos
-
Explore SGS's Comprehensive Biologics Testing Capabilities
2/6/2025
Learn about SGS’s comprehensive Biologics Testing capabilities across two centers of excellence in the U.S. and Canada.
-
Primer Support 5G For Oligonucleotide Synthesis Product Demo
2/3/2025
Primer Support™ 5G solid support is the fifth-generation solid support for oligonucleotide synthesis from Cytiva. By using Cytiva consumables, you can better leverage the whole family knowledge and expertise to efficiently optimize your molecule’s development.
-
ÄKTA Oligosynt™ Synthesizer: With A Little Help From Its Friends
2/3/2025
Cytiva is just about that initial oligo synthesis right? Wrong! Find out all about the synthesis systems friends and family across the full oligo workflow.
-
OligoProcess™ Oligonucleotide Synthesizer Product Overview
2/3/2025
Meet our OligoProcess™ oligonucleotide synthesizer – exceptional scale ranges in 3 different scale designs to fit your needs up to 1800 mmol and beyond.
-
OligoPilot™ Oligonucleotide Synthesizer Product Overview
2/3/2025
Meet our OligoPilot™ oligonucleotide synthesizer – the next generation oligo synthesizer with scales to 150 mmol.
-
ÄKTA Oligosynt™ Oligonucleotide Synthesizer Product Demo
2/3/2025
Meet our ÄKTA oligosynt™ oligonucleotide synthesizer – a small system with a big impact up to 12 mmol.
-
FUJIFILM Diosynth Biotechnologies Capacity Update January 2025: Fill/Finish
1/31/2025
Get an exclusive update on FDB’s current and future Drug Product and Finished Goods capabilities, and discover how their end-to-end CDMO services can support your next project.
-
Capacity Update January 2025: Fill/Finish
1/31/2025
This presentation will showcase our extensive range of offerings, including our advanced high-speed, multi-purpose Fill/Finish line designed for vials, syringes, and cartridges.
-
Forge Biologics, A Member Of Ajinomoto Bio-Pharma Services, Capacity Update January 2025: Cell & Gene Therapy
1/30/2025
See how Forge’s dedicated 200,000 sq. ft. facility, proprietary technologies, and specialized services provide expert AAV manufacturing to empower developers from discovery to delivery and every step in between.
-
Andelyn Biosciences Capacity Update January 2025: Cell & Gene Therapy
1/30/2025
Here we introduce the structure and capabilities of our Laboratory Services group, a cornerstone of our commitment to excellence in pharmaceutical development.